Works matching IS 14611457 AND DT 2021 AND VI 24 AND IP 1


Results: 8
    1
    2
    3
    4

    Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II).

    Published in:
    International Journal of Neuropsychopharmacology, 2021, v. 24, n. 1, p. 22, doi. 10.1093/ijnp/pyaa068
    By:
    • Ionescu, Dawn F;
    • Fu, Dong-Jing;
    • Qiu, Xin;
    • Lane, Rosanne;
    • Lim, Pilar;
    • Kasper, Siegfried;
    • Hough, David;
    • Drevets, Wayne C;
    • Manji, Husseini;
    • Canuso, Carla M
    Publication type:
    Article
    5

    Treatment Discontinuation Impact on Long-Term (10-Year) Weight Gain and Lipid Metabolism in First-Episode Psychosis: Results From the PAFIP-10 Cohort.

    Published in:
    International Journal of Neuropsychopharmacology, 2021, v. 24, n. 1, p. 1, doi. 10.1093/ijnp/pyaa066
    By:
    • Vázquez-Bourgon, Javier;
    • Son, Jaqueline Mayoral-van;
    • Gómez-Revuelta, Marcos;
    • Juncal-Ruiz, María;
    • Foz, Víctor Ortiz-García de la;
    • Tordesillas-Gutiérrez, Diana;
    • Ayesa-Arriola, Rosa;
    • Bioque, Miquel;
    • Crespo-Facorro, Benedicto
    Publication type:
    Article
    6
    7
    8